Australian Clinical Labs
(ASX) ACL
Australian Clinical Labs Financials at a Glance
Market Cap
$391.67M
Revenue (TTM)
$1.46B
Net Income (TTM)
$56.98M
EPS (TTM)
$0.14
P/E Ratio
15.36
Dividend
$0.13
Beta (Volatility)
0.09 (Low)
Dividend
$0.13
Beta (Volatility)
0.09 (Low)
Price
$2.03
Volume
706,282
Open
$2.04
Price
$2.03
Volume
706,282
Open
$2.04
Previous Close
$2.04
Daily Range
$2.00 - $2.05
52-Week Range
$1.92 - $3.24
Dividend
$0.13
Beta (Volatility)
0.09 (Low)
Price
$2.03
Volume
706,282
Open
$2.04
Previous Close
$2.04
Daily Range
$2.00 - $2.05
52-Week Range
$1.92 - $3.24
ACL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Australian Clinical Labs
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
4,700
CEO
Melinda McGrath
Website
www.clinicallabs.com.auHeadquarters
Clayton, VIC 3168, AU
ACL Financials
Key Financial Metrics (TTM)
Gross Margin
29%
Operating Margin
22%
Net Income Margin
4%
Return on Equity
16%
Return on Capital
44%
Return on Assets
5%
Earnings Yield
6.51%
Dividend Yield
0.06%
Payout Ratio
92.80%
Stock Overview
Market Cap
$391.67M
Shares Outstanding
188.31M
Volume
706.28K
Short Interest
0.00%
Avg. Volume
759.76K
Financials (TTM)
Gross Profit
$270.86M
Operating Income
$270.86M
EBITDA
$81.36M
Operating Cash Flow
$182.80M
Capital Expenditure
$8.41M
Free Cash Flow
$174.39M
Cash & ST Invst.
$22.12M
Total Debt
$290.38M
Australian Clinical Labs Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$361.42M
+8.3%
Gross Profit
$68.76M
+13.8%
Gross Margin
19.03%
N/A
Market Cap
$391.67M
N/A
Market Cap/Employee
$79.93K
N/A
Employees
4,900
N/A
Net Income
$5.57M
+12.4%
EBITDA
$86.39M
+8.2%
Quarterly Fundamentals
Net Cash
$430.47M
-42.8%
Accounts Receivable
$60.15M
-18.9%
Inventory
$16.55M
-1.5%
Long Term Debt
$349.24M
+55.0%
Short Term Debt
$104.36M
-48.7%
Return on Assets
4.68%
N/A
Return on Invested Capital
44.01%
N/A
Free Cash Flow
$59.40M
-14.8%
Operating Cash Flow
$62.87M
-14.5%